Alex Mogle
Director/Board Member at MAPI PHARMA LTD
Profile
Alex Mogle is currently a Director at Pharma Two B Ltd.
and a Director & Vice President-Corporate Development at Mapi-Pharma Ltd.
He was previously a Vice President-Strategy at Stem Cell Medicine Ltd.
Mr. Mogle received an undergraduate degree and an MBA from The Hebrew University of Jerusalem.
Alex Mogle active positions
| Companies | Position | Start |
|---|---|---|
| MAPI PHARMA LTD | Director/Board Member | 2012-05-31 |
Pharma Two B Ltd.
 Pharma Two B Ltd. Pharmaceuticals: GenericHealth Technology Pharma Two B Ltd. operates as a biopharmaceutical company which focuses on developing treatments for Parkinson’s disease. The firm focuses on Fixed-Dose-combinations of two or more drugs with synergistic effects, providing clinical value and regulatory pathways. The company was founded by Ehud Marom and Nurit Livnah in December 2007 and is headquartered in Rehovot, Israel. | Director/Board Member | - |
Former positions of Alex Mogle
| Companies | Position | End |
|---|---|---|
Stem Cell Medicine Ltd.
 Stem Cell Medicine Ltd. Pharmaceuticals: OtherHealth Technology Stemcell Medicine Ltd. develops and commercializes cellular therapies. It develops products from a number of tissue sources, such as adipose tissue stem cells for ischemic indications and from T cells for solid tumor-directed immunotherapies. The company was founded by Ehud Marom in 2010 and is headquartered in Jerusalem, IL. | Corporate Officer/Principal | - |
Training of Alex Mogle
| The Hebrew University of Jerusalem | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Mapi-Pharma Ltd.
 Mapi-Pharma Ltd. Pharmaceuticals: MajorHealth Technology Mapi-Pharma Ltd. is a clinical stage pharmaceutical company engaging in the development of extended-release versions of existing commercial generic drugs. Its products include injections for treatment of multiple sclerosis, active pharmaceutical ingredient, and oral drugs for the treatment of neuropathic pain. The company was founded by Ehud Marom in 2008 and is headquartered in Ness Ziona, Israel. | Health Technology |
Stem Cell Medicine Ltd.
Stem Cell Medicine Ltd. Pharmaceuticals: OtherHealth Technology Stemcell Medicine Ltd. develops and commercializes cellular therapies. It develops products from a number of tissue sources, such as adipose tissue stem cells for ischemic indications and from T cells for solid tumor-directed immunotherapies. The company was founded by Ehud Marom in 2010 and is headquartered in Jerusalem, IL. | Health Technology |
Pharma Two B Ltd.
Pharma Two B Ltd. Pharmaceuticals: GenericHealth Technology Pharma Two B Ltd. operates as a biopharmaceutical company which focuses on developing treatments for Parkinson’s disease. The firm focuses on Fixed-Dose-combinations of two or more drugs with synergistic effects, providing clinical value and regulatory pathways. The company was founded by Ehud Marom and Nurit Livnah in December 2007 and is headquartered in Rehovot, Israel. | Health Technology |
- Stock Market
- Insiders
- Alex Mogle
